A deeper mining on the protein composition of VA-MENGOC-BC®: An OMV-based vaccine against N. meningitidis serogroup B and C

References

• Harrison OB, Claus H, Jiang Y, Bennett JS, Bratcher HB, Jolley KA, Corton C, Care R, Poolman JT, Zollinger WD, et al. Description and nomenclature of Neisseria meningitidis capsule locus. Emerg Infect Dis. 2013;19:566–73. doi:10.3201/eid1904.111799. PMID:23628376.
   PubMed Web of Science ®Google Scholar
• Gabutti G, Stefanati A, Kuhdari P. Epidemiology of Neisseria meningitidis infections: case distribution by age and relevance of carriage. J Prev Med Hyg. 2015;56:E116–20. PMID:26788731.
   PubMedGoogle Scholar
• Rouphael NG, Stephens DS. Neisseria meningitidis: Biology, Microbiology, and Epidemiology. Methods Mol Biol. 2012;799:1–20. doi:10.1007/978-1-61779-346-2_1. PMID:21993636.
   PubMedGoogle Scholar
• Finne J, Leinonen M, Makela PH. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet. 1983;2(8346):355–7. doi:10.1016/S0140-6736(83)90340-9. PMID:6135869.
   PubMed Web of Science ®Google Scholar
• Sadarangani M, Pollard AJ. Serogroup B meningococcal vaccines—an unfinished story. Lancet Infect Dis. 2010;10:112–24. doi:10.1016/S1473-3099(09)70324-X. PMID:20113980.
   PubMed Web of Science ®Google Scholar
• Gasparini R, Amicizia D, Domnich A, Lai PL, Panatto D. Neisseria meningitidis B vaccines: recent advances and possible immunization Policies. Expert Rev Vaccine. 2014;13:345–64. doi:10.1586/14760584.2014.880341.
   PubMed Web of Science ®Google Scholar
• Loring BJ, Turner N, Petousis-Harris H. MeNZB™ vaccine and epidemic control: When do you stop vaccinating? Vaccine. 2008;26:5899–904. doi:10.1016/j.vaccine.2008.08.062. PMID:18804134.
   PubMed Web of Science ®Google Scholar
• Tappero JW, Lagos R, Ballesteros AM, Plikaytis B, Williams D, Dykes J, Gheesling LL, Carlone GM, Høiby EA, Holst J, et al. Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile. JAMA. 1999;281(16):1520–7. doi:10.1001/jama.281.16.1520. PMID:10227322.
   PubMed Web of Science ®Google Scholar
• Donnelly J, Medini D, Boccadifuoco G, Biolchi A, Ward J, Frasch C, Richard-Moxon E, Stella M, Comanducci M, Bambini S, et al. Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines. PNAS 9. 2010;107:19490–5. doi:10.1073/pnas.1013758107.
   PubMed Web of Science ®Google Scholar
• Sierra GV, Campa HC, Varcacel NM, Garcia IL, Izquierdo PL, Sotolongo PF, Casanueva GV, Rico CO, Rodriguez CR, Terry MH. Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. NIPH Ann. 1991;14:195–210. PMID:1812432.
   PubMedGoogle Scholar
• Sotolongo F, Campa C, Casanueva V, Fajardo EM, Cuevas IE, González N. Cuban Meningococcal BC Vaccine: Experiences & Contributions from 20 Years of Application. MEDICC Rev. 2017:9(1):16–22. PMID:21487356.
   PubMedGoogle Scholar
• Sierra G, Campa C, García IL, Sotolongo F, Izquierdo L, Valcárcel M, Casanueva V, Baró M, Leguen F, Rodríguez R, Terry H. Efficacy evaluation of the Cuban vaccine VA-MENGOC-BC against disease caused by serogroup B Neisseria meningitidis. In: M Atchman et al., editors. Neisseria. Berlin: Walter Gruyter; 1990. p. 129–34.
   Google Scholar
• Costa EA. On the Controversy about the Efficacy of the Antimeningococcal B Vaccine: Methodological Pitfalls. Cad Saúde Públ. 1995;11(2):332–5. doi:10.1590/S0102-311X1995000200018.
   PubMedGoogle Scholar
• Costa E, Martins HJ, Klein CH. Avaliação da proteção conferida pela vacina antimeningocócica BC no Estado de Santa Catarina, Brazil, 1990/92. Rev Saúde Pública. 1996;30(5):460–70. doi:10.1590/S0034-89101996000500009.
   PubMedGoogle Scholar
• Galeano LA, Echeverry ML. Efectividad de una vacuna antimeningocócica en una cohorte de Itaguí Colombia, 1995. Boletín Epidemiológico de Antioquia. 1996;20(2):110–8.
   Google Scholar
• Williams JN, Weynants V, Poolman JT, Heckels JE, Christodoulides M. Immuno-proteomic analysis of human immune responses to experimental Neisseria meningitides outer membrane vesicle vaccines identifies potential cross-reactive antigens. Vaccine. 32;2014:1280–86. doi:10.1016/j.vaccine.2013.12.070. PMID:24486354.
   PubMed Web of Science ®Google Scholar
• Santoni V, Molloy M, Rabilloud T. Membrane proteins and proteomics: Un amour impossible? Electrophoresis. 2000;21:1054–70. doi:10.1002/(SICI)1522-2683(20000401)21:6%3c1054::AID-ELPS1054%3e3.0.CO;2-8 10.1002/(SICI)1522-2683(20000401)21:6%3c1054::AID-ELPS1054%3e3.3.CO;2-. PMID:10786880.
   PubMed Web of Science ®Google Scholar
• Wu CC, Yates JR III. The application of mass spectrometry to membrane proteomics. Nat Biotechnol. 2003;21:262–7. doi:10.1038/nbt0303-262. PMID:12610573.
   PubMed Web of Science ®Google Scholar
• Uli L, Castellanos-Serra L, Betancourt L, Domínguez F, Barberá R, Sotolongo F, Guillén G, Pajón Feyt R. Outer membrane vesicles of the VA-MENGOC-BC vaccine against serogroup B of Neisseria meningitidis: Analysis of protein components by two-dimensional gel electrophoresis and mass spectrometry. Proteomics. 2006;6:3389–99. doi:10.1002/pmic.200500502. PMID:16673438.
   PubMed Web of Science ®Google Scholar
• Ramos Y, Gutierrez E, Machado Y, Sanchez A, Castellanos-Serra L, González LJ, Fernandez-de-Cossio J, Perez Y, Betancourt L, Gil J, et al. Proteomics based on peptide fractionation by SDS-free PAGE. J Proteome Res. 2008;7:2427–34. doi:10.1021/pr700840y. PMID:18422305.
   PubMed Web of Science ®Google Scholar
• Betancourt L, Gil J, Besada V, González LJ, Fernández-de-Cossio J, García L, Pajón R, Sanchez A, Alvarez F, Padrón G. SCAPE: a new tool for the Selective CApture of PEptides in protein identification. J Proteome Res. 2005;4:491–6. doi:10.1021/pr049794x. PMID:15822926.
   PubMed Web of Science ®Google Scholar
• Gil J, Betancourt L, Sardiñas G, Yero D, Niebla O, Delgado M, García D, Pajón R, Sanchez A, González LJ, et al. Proteomic study via a non-gel based approach of meningococcal outer membrane vesicle vaccine obtained from strain CU385: a road map for discovery new antigens. Hum Vaccin. 2009;5:347–56. doi:10.4161/hv.5.5.7367. PMID:19377283.
   PubMed Web of Science ®Google Scholar
• Furka A, Sebestyén F, Asgedom M, Dibó G. General method for rapid synthesis of multicomponent peptide mixtures. Int J Pept Protein Res. 1991;37:487–93. doi:10.1111/j.1399-3011.1991.tb00765.x. PMID:1917305.
   PubMedGoogle Scholar
• Thulasiraman V, Lin S, Gheorghiu L, Lathrop J, Lomas L, Hammond D, Boschetti E. Reduction of the concentration difference of proteins in biological liquids using a library of combinatorial ligands. Electrophoresis. 2005;26:3561–71. doi:10.1002/elps.200500147. PMID:16167368.
   PubMed Web of Science ®Google Scholar
• Sennels L, Salek M, Lomas L, Boschetti E, Righetti PG, Rappsilber J. Proteomic analysis of human blood serum using peptide library beads. J Proteome Res. 2007;6:4055–62. doi:10.1021/pr070339l. PMID:17877382.
   PubMed Web of Science ®Google Scholar
• Guerrier L, Claverol S, Finzi L, Paye F, Fortis F, Boschetti E, Housset C. Contribution of solid-phase hexapeptide ligand libraries to the repertoire of human bile proteins. J Chromatogr A. 2007;1176:192–205. doi:10.1016/j.chroma.2007.11.007. PMID:18036598.
   PubMed Web of Science ®Google Scholar
• Castagna A, Cecconi D, Sennels L, Rappsilber J, Guerrier L, Fortis F, Boschetti E, Lomas L, Righetti PG. Exploring the hidden human urinary proteome via ligand library beads. J Proteome Res. 2005;4:1917–30. doi:10.1021/pr050153r. PMID:16335936.
   PubMed Web of Science ®Google Scholar
• Guerrier L, Claverol S, Fortis F, Rinalducci S, Timperio AM, Antonioli P, Jandrot-Perrus M, Boschetti E, Righetti PG. Exploring the platelet proteome via combinatorial, hexapeptide ligand libraries. J Proteome Res. 2007;6:4290–303. doi:10.1021/pr0703371. PMID:17918985.
   PubMed Web of Science ®Google Scholar
• Roux-Dalvai F, Gonzalez de Peredo A, Simó C, Guerrier L, Bouyssié D, Zanella A, Citterio A, Burlet-Schiltz O, Boschetti E, Righetti PG, et al. Extensive analysis of the cytoplasmic proteome of human erythrocytes using the peptide ligand library technology and advanced mass spectrometry. Mol Cell Proteomics. 2008;7:2254–69. doi:10.1074/mcp.M800037-MCP200. PMID:18614565.
   PubMed Web of Science ®Google Scholar
• Boschetti E, Righetti PG. The art of observing rare protein species in proteomes with peptide ligand libraries. Proteomics. 2009;9:1492–510. doi:10.1002/pmic.200800389. PMID:19235170.
   PubMed Web of Science ®Google Scholar
• D'Ambrosio C, Arena S, Scaloni A, Guerrier L, Boschetti E, Mendieta ME, Citterio A, Righetti PG. Exploring the chicken egg white proteome with combinatorial peptide ligand libraries. J Proteome Res. 2008;7:3461–74. doi:10.1021/pr800193y. PMID:18570458.
   PubMed Web of Science ®Google Scholar
• Washburn MP, Wolters D, Yates JR III. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol. 2001;19:242–47. doi:10.1038/85686. PMID:11231557.
   PubMed Web of Science ®Google Scholar
• Hörth P, Miller CA, Preckel T, Wenz C. Efficient fractionation and improved protein identification by peptide OFFGEL electrophoresis. Mol Cell Proteomics. 2006;5:1968–74. doi:10.1074/mcp.T600037-MCP200. PMID:16849286.
   PubMed Web of Science ®Google Scholar
• Geiger T, Velic A, Macek B, Lundberg E, Kampf C, Nagaraj N, Uhlen M, Cox J, Mann M. Initial quantitative proteomic map of 28 mouse tissues using the SILAC mouse. Mol Cell Proteomics. 2013;12:1709–22. doi:10.1074/mcp.M112.024919. PMID:23436904.
   PubMed Web of Science ®Google Scholar
• Gilar M, Olivova P, Daly AE, Gebler JC. Two-dimensional separation of peptides using RP- RP-HPLC system with different pH in first and second separation dimension. J Sep Sci. 2005;28:1694–703. doi:10.1002/jssc.200500116. PMID:16224963.
   PubMed Web of Science ®Google Scholar
• Mihailova A, Lundanes E, Greibrok T. Determination and removal of impurities in 2-DLC-MS of peptides. J Sep Sci. 2006;29:576–81. doi:10.1002/jssc.200500496. PMID:16583696.
   PubMed Web of Science ®Google Scholar
• Yu NY, Wagner JR, Laird MR, Melli G, Rey S, Lo R, Dao P, Sahinalp SC, Ester M, Foster LJ, et al. PSORTb 3.0: Improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics. 2010;26:1608–15. doi:10.1093/bioinformatics/btq249. PMID:20472543.
   PubMed Web of Science ®Google Scholar
• Tettelin H, Saunders NJ, Heidelberg JF, Jeffries AC, Nelson KE, Eisen JA, Ketchum KA, Hood DW, Peden JF, Dodson RJ, et al. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science. 2000;287:1809–15. doi:10.1126/science.287.5459.1809. PMID:10710307.
   PubMed Web of Science ®Google Scholar
• Grifantini R, Bartolini E, Muzzi A, Draghi M, Frigimelica E, Berger J, Ratti G, Petracca R, Galli G, Agnusdei M, et al. Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays. Nat Biotechnol. 2002;20:914–21. doi:10.1038/nbt728. PMID:12172557.
   PubMed Web of Science ®Google Scholar
• Callaghan MJ, Jolley KA, Maiden MC. Opacity-associated adhesin repertoire in hyperinvasive Neisseria meningitidis. Infect Immun. 2006;74:5085–94. doi:10.1128/IAI.00293-06. PMID:16926400.
   PubMed Web of Science ®Google Scholar
• Ferrari G, Garaguso I, Adu-Bobie J, Doro F, Taddei AR, Biolchi A, Brunelli B, Giuliani MM, Pizza M, Norais N, et al. Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles. Proteomics. 2006;6:1856–66. doi:10.1002/pmic.200500164. PMID:16456881.
   PubMed Web of Science ®Google Scholar
• Rohde KH, Gillaspy AF, Hatfield MD, Lewis LA, Dyer DW. Interactions of hemoglobin with the Neisseria meningitidis receptor HpuAB: the role of TonB and an intact proton motive force. Mol Microbiol. 2002;43:335–54. doi:10.1046/j.1365-2958.2002.02745.x. PMID:11985713.
   PubMed Web of Science ®Google Scholar
• Piet JR, Huis int Veld RAG, van Schaik BDC, van Kampen AHC, Baas F, van de Beek D, Pannekoek Y, van der Ende A. Genome Sequence of Neisseria meningitidis Serogroup B Strain H44/76 J. Bacteriol. 2011;193:2371–72. doi:10.1128/JB.01331-10.
   PubMed Web of Science ®Google Scholar
• Marchler-Bauer A, Derbyshire MK, Gonzales NR, Lu S, Chitsaz F, Geer LY, Geer RC, He J, Gwadz M, Hurwitz DI, et al. CDD: NCBI's conserved domain database. Nucleic Acids Res. 2015;43:222–6. doi:10.1093/nar/gku1221.
   PubMed Web of Science ®Google Scholar
• Melvin JA, Scheller EV, Noël CR, Cotter PA. New insight into filamentous hemagglutinin secretion reveals a role for full-length FhaB in Bordetella virulence. mBio. 2015;6:e01189–15. doi:10.1128/mBio.01189-15. PMID:26286694.
   PubMed Web of Science ®Google Scholar
• Shippy DC, Fadl AA. tRNA modification enzymes GidA and MnmE: potential role in virulence of bacterial pathogens. Int J Mol Sci. 2014;15:18267–80. doi:10.3390/ijms151018267. PMID:25310651.
   PubMed Web of Science ®Google Scholar
• Frasch CE, Borrow R, Donelly J. Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease. Vaccine. 2009;27:B112–6. doi:10.1016/j.vaccine.2009.04.065. PMID:19464093.
   PubMed Web of Science ®Google Scholar
• Pettersson A, Kortekaas J, Weynants VE, Pierre Poolman VJT, Bos MP, Tommassen J. Vaccine potential of the Neisseria meningitidis lactoferrin-binding proteins LbpA and LbpB. Vaccine. 2006;17:243545–57.
   Google Scholar
• Norheim G, Aase A, Caugant DA, Høiby A, Fritzsønn E, Tangen T, Kristiansen P, Heggelund U, Rosenqvist E. Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis. Vaccine. 2005;23:3762–74. doi:10.1016/j.vaccine.2005.02.021. PMID:15893613.
   PubMed Web of Science ®Google Scholar
• Weynants VE, Feron CM, Goraj KK, Bos MP, Denoe PA, Verlant VG, Tommassen J, Peak IRA, Judd RC, et al. Additive and synergistic bactericidal activity of antibodies directed against minor outer membrane proteins of neisseria meningitidis. Infect Immun. 2007;75:5434–42. doi:10.1128/IAI.00411-07. PMID:17664268.
   PubMed Web of Science ®Google Scholar
• Pettersson A, Kuipers B, Pelzer M, Verhagen E, Tiesjema RH, Tommassen J, Poolman JT. Monoclonal antibodies against the 70-kilodalton iron-regulated protein of Neisseria meningitidis are bactericidal and strain specific. Infect Immun. 1990;58:3036–41. PMID:1696939.
   PubMed Web of Science ®Google Scholar
• Haghi F, Peerayeh SN, Siadat SD, Zeighami H. Recombinant outer membrane secretin PilQ(406-770) as a vaccine candidate for serogroup B Neisseria meningitidis. Vaccine. 2012;30:1710–4. doi:10.1016/j.vaccine.2011.12.076. PMID:22234267.
   PubMed Web of Science ®Google Scholar
• Serruto D, Adu-Bobie J, Scarselli M, Veggi D, Pizza M, Rappuoli R, Arico B. Neisseria meningitidis App, a new adhesin with autocatalytic serine protease activity. Mol Microbiol. 2003;48:323–34. doi:10.1046/j.1365-2958.2003.03420.x. PMID:12675794.
   PubMed Web of Science ®Google Scholar
• Turner PC, Thomas CE, Stojiljkovic I, Elkins C, Kizel G, Ala'Aldeen DAA, Sparling PF. Neisserial TonB-dependent outer-membrane proteins: detection, regulation and distribution of three putative candidates identified from the genome sequences. Microbiology. 2001;147:1277–90. doi:10.1099/00221287-147-5-1277. PMID:11320131.
   PubMed Web of Science ®Google Scholar
• Turner DPJ, Marietou AG, Johnston L, Ho KKL, Rogers AJ, Wooldridge KG, Ala'Aldeen DAA. Characterization of MspA, an immunogenic autotransporter protein that mediates adhesion to epithelial and endothelial cells in Neisseria meningitidis. Infect Immun. 2006;74:2957–64. doi:10.1128/IAI.74.5.2957-2964.2006. PMID:16622234.
   PubMed Web of Science ®Google Scholar
• Gupta SK, Smita S, Sarangi AN, Srivastava M, Akhoon BA, Rahman Q, Gupta SK. In silico CD4+ T-cell epitope prediction and HLA distribution analysis for the potential proteins of Neisseria meningitidis Serogroup B—A clue for vaccine development. Vaccine. 2010;28:7092–97. doi:10.1016/j.vaccine.2010.08.005. PMID:20716448.
   PubMed Web of Science ®Google Scholar
• Adu-Bobie J, Lupetti P, Brunelli B, Granoff D, Norais N, Ferrari G, Grandi G, Rappuoli R, Pizza M. GNA33 of Neisseria meningitidis is a lipoprotein required for cell separation, membrane architecture, and virulence. Infect Immun. 2004;72:1914–9. doi:10.1128/IAI.72.4.1914-1919.2004. PMID:15039310.
   PubMed Web of Science ®Google Scholar
• Martin D, Brodeur BR, Hamel J, Couture F, Alwis U, Lian Z, Martin S, Andrews D, Ellis RW. Candidate Neisseria meningitidis NspA vaccine. J Biotechnol. 2000;83:27–31. doi:10.1016/S0168-1656(00)00294-7. PMID:11000456.
   PubMed Web of Science ®Google Scholar
• Shirley M, Dhillon S. Bivalent rLP2086 vaccine (Trumenba®): A review in active immunization against invasive meningococcal group B disease in individuals aged 10–25 years. BioDrugs. 2015;29(5):353–61. doi:10.1007/s40259-015-0139-0. PMID:26394633.
   PubMed Web of Science ®Google Scholar
• Serruto D, Spadafina T, Ciucchi L, Lewis LA, Ram S, Tontini M, Santini L, Biolchi A, Seib KL, Giuliani MM, et al. Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans. Proc Natl Acad Sci U S A. 2010;107:3770–75. doi:10.1073/pnas.0915162107. PMID:20133713.
   PubMed Web of Science ®Google Scholar
• Esposito S, Principi N. Vaccine profile of 4CMenB: a four-component Neisseria meningitidis serogroup B vaccine. Expert Rev Vaccines. 2014;13:193–202. doi:10.1586/14760584.2014.874949. PMID:24393061.
   PubMed Web of Science ®Google Scholar
• Ochoa-Azze R, García-Imia L. Efectividad de la vacuna VA-MENGOC-BC® contra cepas heterólogas de meningococo B. VacciMonitor. 2016;25(2):43–48.
   Google Scholar
• Pajon R, Yero D, Niebla O, Climent Y, Sardiñas G, García D, Perera Y, Llanes A, Delgado M, Cobas K, et al. Identification of new meningococcal serogroup B surface antigens through a systematic analysis of neisserial genomes. Vaccine. 28;2009:532–41. doi:10.1016/j.vaccine.2009.09.128. PMID:19837092.
   PubMed Web of Science ®Google Scholar
• Sardiñas G, Yero D, Climent Y, Caballero E, Cobas K, Niebla O. Neisseria meningitidis antigen NMB0088: sequence variability, protein topology and vaccine potential. J Med Microbiol. 2009;58:196–208. doi:10.1099/jmm.0.004820-0. PMID:19141737.
   PubMed Web of Science ®Google Scholar
• Delgado M, Yero D, Niebla O, González S, Climent Y, Pérez Y, Cobas K, Caballero E, García D, Pajón R. Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate. Vaccine. 2007;25:8420–31. doi:10.1016/j.vaccine.2007.09.053. PMID:17996338.
   PubMed Web of Science ®Google Scholar
• Wolters DA, Washburn MP, Yates JR III. An automated multidimensional protein identification technology for shotgun proteomics. Anal Chem. 2001;73:5683–5690. doi:10.1021/ac010617e. PMID:11774908.
   PubMed Web of Science ®Google Scholar
• Millar AH, Heazlewood JL. Genomic and proteomic analysis of mitochondrial carrier proteins in Arabidopsis. Plant Physiol. 2003;131:443–53. doi:10.1104/pp.103.028399 10.1104/pp.009985. PMID:12586869.
   PubMed Web of Science ®Google Scholar
• Joseph B, Schneiker-Bekel S, Schramm-Gluck A, Blom J, Claus H, Linke B, Schwarz RF, Becker A, Goesmann A, Frosch M, et al. Comparative genome biology of a serogroup B carriage and disease strain supports a polygenic nature of meningococcal virulence. J Bacteriol. 2010;192:5363–77. doi:10.1128/JB.00883-10. PMID:20709895.
   PubMed Web of Science ®Google Scholar
• Parkhill J, Achtman M, James KD, Bentley SD, Churcher C, Klee SR, Morelli G, Basham D, Brown D, Chillingworth T, et al. Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491. Nature. 2000;404:502–06. doi:10.1038/35006655. PMID:10761919.
   PubMed Web of Science ®Google Scholar
• Bambini S, Piet J, Muzzi A, Keijzers W, Comandi S, De Tora L, Pizza M, Rappuoli R, van de Beek D, van der Ende A, et al. An analysis of the sequence variability of meningococcal fHbp, NadA and NHBA over a 50-year period in the Netherlands. PLoS ONE. 2013;8:e65043. doi:10.1371/journal.pone.0065043. PMID:23717687.
   PubMed Web of Science ®Google Scholar
• Muzzi A, Mora M, Pizza M, Rappuoli R, Donati C. Conservation of meningococcal antigens in the genus Neisseria. mBio. 2013;4:e00163–13. doi:10.1128/mBio.00163-13. PMID:23760461.
   PubMed Web of Science ®Google Scholar
• Koeberling O, Seubert A, Granoff DM. Bactericidal antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed factor H–binding protein and genetically attenuated endotoxin. J Infect Dis. 2008;198:262–70. doi:10.1086/589308. PMID:18505380.
   PubMed Web of Science ®Google Scholar
• Masignani V, Comanducci M, Giuliani MM, Bambini S, Adu-Bobie J, Aricò B, Brunelli B, Pieri A, Santini L, Savino S, et al. Vaccination against neisseria meningitides using three variants of the lipoprotein GNA1870. J Exp Med. 2003;197:789–99. doi:10.1084/jem.20021911. PMID:12642606.
   PubMed Web of Science ®Google Scholar
• Vipond C, Wheeler JX, Jones C, Feavers IM, Suker J. Characterization of the protein content of a meningococcal outer membrane vesicle vaccine by polyacrylamide gel electrophoresis and mass spectrometry. Hum Vaccine. 2005;1:80–84. doi:10.4161/hv.1.2.1651.
   PubMed Web of Science ®Google Scholar
• Williams JN, Skipp PJ, Humphries HE, Christodoulides M, O'Connor CD, Heckels JE. Proteomic analysis of outer membranes and vesicles from wild-type serogroup B Neisseria meningitidis and a lipopolysaccharide-deficient mutant. Infect Immun. 2007;75:1364–72. doi:10.1128/IAI.01424-06. PMID:17158897.
   PubMed Web of Science ®Google Scholar
• Weber MVR, Hammerschmidt S, Bergmann S, Frosch M, Kurzai O. Cytosolic proteins contribute to surface plasminogen recruitment of neisseria meningitidis. J Bacteriol. 2007;189:3246–55. doi:10.1128/JB.01966-06. PMID:17307854.
   PubMed Web of Science ®Google Scholar
• Tunio SA, Oldfield NJ, Berry A, Ala'Aldeen DAA, Wooldridge KG, Turner DPJ. The moonlighting protein fructose-1, 6-bisphosphate aldolase of Neisseria meningitidis: surface localization and role in host cell adhesion. Mol Microbiol. 2010;76:605–15. doi:10.1111/j.1365-2958.2010.07098.x. PMID:20199602.
   PubMed Web of Science ®Google Scholar
• Snyder LAS, Saunders NJ. The majority of genes in the pathogenic Neisseria species are present in non-pathogenic Neisseria lactamica, including those designated as virulence genes. BMC Genomics. 2006;7:128. doi:10.1186/1471-2164-7-128. PMID:16734888.
   PubMed Web of Science ®Google Scholar
• Bos MP, Tommassen J. The LptD chaperone LptE is not directly involved in lipopolysaccharide transport in Neisseria meningitidis. J Biol Chem. 2011;286:28688–96. doi:10.1074/jbc.M111.239673. PMID:21705335.
   PubMed Web of Science ®Google Scholar
• Dutta A, Bhattacharyya S, Kundu A, Dutta D, Das AK. Macroscopic amyloid fiber formation by staphylococcal biofilm associated SuhB protein. Biophys Chem. 2016;217:32–41. doi:10.1016/j.bpc.2016.07.006. PMID:27497060.
   PubMed Web of Science ®Google Scholar
• Zhong W, Xu W, Wang H, Huang Y, Cao J, Gong Y, Xu X, Min X, Zhang Y, Dong J, et al. Mucosal immunization with caseinolytic protease X elicited cross-protective immunity against pneumococcal infection in mice. Exp Biol Med (Maywood). 2012;237:694–702. doi:10.1258/ebm.2012.011383. PMID:22728705.
   PubMed Web of Science ®Google Scholar
• Mendum TA, Newcombe J, McNeilly CL, McFadden J. Towards the immunoproteome of Neisseria meningitidis. PLOS ONE. 2009;4:e5940. doi:10.1371/journal.pone.0005940. PMID:19529772.
   PubMed Web of Science ®Google Scholar
• Williams JN, Skipp PJ, O'Connor CD, Christodoulides M, Heckels JE. Immunoproteomic analysis of the development of natural immunity in subjects colonized by neisseria meningitidis reveals potential vaccine candidates. Infect Immun. 2009;77:5080–9. doi:10.1128/IAI.00701-09. PMID:19737898.
   PubMed Web of Science ®Google Scholar
• Williams JN, Weynants V, Poolman JT, Heckels JE, Christodoulides M. Immuno-proteomic analysis of human immune responses to experimental Neisseria meningitidis outer membrane vesicle vaccines identifies potential cross-reactive antigens. Vaccine. 2014;32:1280–6. doi:10.1016/j.vaccine.2013.12.070. PMID:24486354.
   PubMed Web of Science ®Google Scholar
• Grifantini R, Bartolini E, Muzzi A, Draghi M, Frigimelica E, Berger J, Ratti G, Petracca R, Galli G, Agnusdei M, et al. Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays. Nat Biotechnol. 2002;20:914–21. doi:10.1038/nbt728. PMID:12172557.
   PubMed Web of Science ®Google Scholar
• Finney M, Vaughan T, Taylor S, Hudson MJ, Pratt C, Wheeler JX, Vipond C, Feavers I, Jones C, Findlow J, et al. Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles. Hum Vaccines. 2008;4:23–30. doi:10.4161/hv.4.1.4806.
   PubMed Web of Science ®Google Scholar
• Tsolakos N, Lie K, Bolstad K, Maslen S, Kristiansen PA, Hoiby EA, Wallington A, Vipond C, Skehel M, Tang CM, et al. Characterization of meningococcal serogroup B outer membrane vesicle vaccines from strain 44/76 after growth in different media. Vaccine. 2010;28,3211–18. doi:10.1016/j.vaccine.2010.02.023. PMID:20188677.
   PubMed Web of Science ®Google Scholar
• Galien S, Duriez E, Domon B. Selective reaction monitoring applied to proteomics. J Mass Spectrom. 2011;46:298–312. doi:10.1002/jms.1895. PMID:21394846.
   PubMed Web of Science ®Google Scholar
• Desiderio DE, Kai M. Preparation of stable isotope-incorporated peptide internal standards for field desorption mass spectrometry quantification of peptides in biologic tissue. Biomed Mass Spectrom. 1983;10, 471–9. doi:10.1002/bms.1200100806. PMID:6616023.
   PubMedGoogle Scholar
• Barr JR, Magio VL, Patterson DG, Cooper GR Jr, Henderson LO, Turner WE, Smith SJ, Hannon WH, Needham LL, Sampson EJ. Isotope dilution-mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I. Clin Chem. 1996;42:1676–82. PMID:8855153.
   PubMed Web of Science ®Google Scholar
• Atherton E, Sheppard RC. Solid phase peptide synthesis: a practical approach. In: Coligan JE, Dunn BM, Ploegh HL, editors. Current protocols in protein science. Oxford: IRL Press; 1989; pp. 1–216.
   Google Scholar
• Guerrier L, Thulasiraman V, Castagna A, Fortis F, Lin S, Lomas L, Righetti PG, Boschetti E. Reducing protein concentration range of biological samples using solid-phase ligand libraries. J Chromatogr B Analyt Technol Biomed Life Sci. 2006;833:33–40. doi:10.1016/j.jchromb.2005.12.048. PMID:16455314.
   PubMed Web of Science ®Google Scholar
• Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–5. doi:10.1038/227680a0. PMID:5432063.
   PubMed Web of Science ®Google Scholar
• Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis. 1999;20:3551–67. doi:10.1002/(SICI)1522-2683(19991201)20:18%3c3551::AID-ELPS3551%3e3.0.CO;2-2. PMID:10612281.
   PubMed Web of Science ®Google Scholar
• The UniProt Consortium. UniProt: a hub for protein information. Nucleic Acids Res. 2015;43:D204–12. doi:10.1093/nar/gku989. PMID:25348405.
   PubMed Web of Science ®Google Scholar